zeneca zd 6169 has been researched along with 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one in 1 studies
| Studies (zeneca zd 6169) | Trials (zeneca zd 6169) | Recent Studies (post-2010) (zeneca zd 6169) | Studies (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one) | Trials (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one) | Recent Studies (post-2010) (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one) |
|---|---|---|---|---|---|
| 42 | 0 | 3 | 793 | 0 | 110 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, KE; Mizusawa, H; Pandita, RK | 1 |
1 other study(ies) available for zeneca zd 6169 and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
| Article | Year |
|---|---|
Intravesical oxyhemoglobin initiates bladder overactivity in conscious, normal rats.
Topics: Administration, Intravesical; Amides; Animals; Arginine; Benzophenones; Enzyme Inhibitors; Female; Free Radical Scavengers; Guanylate Cyclase; Nitric Oxide; Oxadiazoles; Oxyhemoglobins; Potassium Channels; Quinoxalines; Rats; Rats, Sprague-Dawley; Urinary Bladder; Urination; Urothelium | 2000 |